awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33554356-7D52E9A0-58A0-470E-9681-F81814EEAFEE
Q33554356-7D52E9A0-58A0-470E-9681-F81814EEAFEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33554356-7D52E9A0-58A0-470E-9681-F81814EEAFEE
The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.
P2860
Q33554356-7D52E9A0-58A0-470E-9681-F81814EEAFEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33554356-7D52E9A0-58A0-470E-9681-F81814EEAFEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e272845873ae7991ec5f2c1b06e9c7858b726799
P2860
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.